Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
24.55
+0.02 (0.10%)
At close: Apr 28, 2026, 4:00 PM EDT
24.55
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:15 PM EDT
0.10% (1D)
| Assets | $723.60M |
| Expense Ratio | 0.13% |
| PE Ratio | 19.55 |
| Shares Out | 29.29M |
| Dividend (ttm) | $0.02 |
| Dividend Yield | 0.09% |
| Ex-Dividend Date | Dec 24, 2025 |
| Payout Ratio | 1.81% |
| 1-Year Return | n/a |
| Volume | 94,176 |
| Open | 24.61 |
| Previous Close | 24.53 |
| Day's Range | 24.46 - 24.67 |
| 52-Week Low | 24.18 |
| 52-Week High | 27.47 |
| Beta | n/a |
| Holdings | 55 |
| Inception Date | Nov 24, 2025 |
About PBPH
Fund Home PageThe Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a rules-based index of healthcare companies that derive at least 50% of their revenue from pharmaceutical and/or biotechnology activities. Securities are selected using BITAs thematic methodology and weighted by market cap. PBPH was launched on Nov 24, 2025 and is issued by Portfolio Building Block.
Asset Class Equity
Category Health
Region Global
Stock Exchange NASDAQ
Ticker Symbol PBPH
ETF Provider Portfolio Building Block
Index Tracked BITA Global Pharma and Biotech Select Index
Top 10 Holdings
58.76% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.47% |
| Johnson & Johnson | JNJ | 9.16% |
| AbbVie Inc. | ABBV | 5.87% |
| Roche Holding AG | ROP | 4.74% |
| Merck & Co., Inc. | MRK | 4.62% |
| AstraZeneca PLC | AZN | 4.60% |
| Novartis AG | NOVN | 4.55% |
| Amgen Inc. | AMGN | 4.38% |
| Gilead Sciences, Inc. | GILD | 4.30% |
| Pfizer Inc. | PFE | 4.07% |
News
What Johnson & Johnson Earnings Signal for Healthcare ETFs
With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthcare giant beat expectations on Tuesday in r...
14 days ago - ETF Trends